Sea Crest Wealth Management, LLC T2 Biosystems, Inc. Transaction History

Sea Crest Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$2.56 - $4.48 $75,479 - $132,088	-29,484 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$2.98 - $6.86 $8,940 - $20,580	3,000 Added 11.33%	29,484 $89,000
Q3 2018 Nov 14, 2018	BUY	$5.36 - $7.83 $50,255 - $73,414	9,376 Added 54.8%	26,484 $197,000
Q2 2018 Aug 03, 2018	BUY	$5.97 - $9.58 $102,134 - $163,894	17,108 New	17,108 $132,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.